Please login to the form below

Not currently logged in
Email:
Password:

STEM

This page shows the latest STEM news and features for those working in and with pharma, biotech and healthcare.

GSK hands rare disease assets over to Orchard

GSK hands rare disease assets over to Orchard

stem cell transplants to restore normal gene functions.

Latest news

More from news
Approximately 16 fully matching, plus 330 partially matching documents found.

Latest Intelligence

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    way under the cost-effective price and significantly lower than the current standard of allogenic stem cell transplant that costs $500, 000-800, 000 in the first year with follow-up

  • Deal Watch January 2018

    Takeda moves in neurodegenerative diseases and stem cell therapy. Meanwhile Takeda, ranked 4. ... Option exercise (2 options). 640. TiGenix/Takeda. Cx601, lead asset, allogeneic expanded adipose-derived stem cells (eASC) locally administered for

  • The good, the bad and the ugly The good, the bad and the ugly

    Roche is hoping to stem revenue loss by introducing new formulations, combining older drugs with newer agents, or relying on newer drugs to make up for the revenue loss.

  • Academic-industry collaboration in the era of big data Academic-industry collaboration in the era of big data

    Almost half of all the UK academic publications stem from international collaborations and, despite vague reassurances, many university leaders see some clearly restrictive new barriers to such international partnerships.

  • Pushing the accelerator Pushing the accelerator

    Most of the process inefficiencies in today’s drug development environment stem from longstanding operational silos between internal stakeholders.

More from intelligence
Approximately 1 fully matching, plus 41 partially matching documents found.

Latest appointments

  • Simon Doyle joins STEM Simon Doyle joins STEM

    Simon Doyle joins STEM. He takes up a position as vice president, global customer relations development. ... Benchmarking company STEM has appointed Simon Doyle as its new vice president of global customer relations and development.

  • Storm Therapeutics bolsters its team Storm Therapeutics bolsters its team

    As a clinician-scientist at the University of Melbourne, Professor Dawson has experience in epigenetics having spent several years researching epigenetic regulation of leukaemia stem cells.

  • Porterhouse Medical promotes Emma Conran Porterhouse Medical promotes Emma Conran

    Conran has served in medical writing positions at Porterhouse Medical since 2014 and prior to that she was a translational stem cell biology lecturer at King’s College London.

  • STEM Healthcare bolsters its EU5 team STEM Healthcare bolsters its EU5 team

    STEM Healthcare bolsters its EU5 team. Adds four new hires to support growth across the region. ... Jason Brown, president of EU5, STEM, said: “I’m delighted to welcome such high calibre professionals with deep experience from across the

  • apceth Biopharma appoints Dusan Kosijer as CFO apceth Biopharma appoints Dusan Kosijer as CFO

    Moreover, Dusan’s experience will strongly promote our dynamic innovative strategy behind apceth’s unique proprietary pipeline of genetically modified stem cell therapies.”.

More from appointments
Approximately 3 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics